ChAdOx1-S [recombinant]

BIOLOGICAL2 trials

Sponsors

Canadian Immunization Research Network, Universiteit Antwerpen

Conditions

COVID-19Coronavirus Disease 2019

Phase 2

Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity

Active, not recruitingNCT04894435

Canadian Immunization Research NetworkCOVID-19

Start: 2021-05-20End: 2025-08-01Updated: 2025-03-18

Phase 4

Immunogenicity After COVID-19 Vaccines in Adapted Schedules

CompletedNCT06189040

Universiteit AntwerpenCoronavirus Disease 2019, COVID-19

Start: 2021-05-26End: 2022-07-08Updated: 2024-01-03

Related Papers

Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial.

2024-07-162 citations